An interventional study of Low Intensity Resistance Training with Maximal Mental Effort and Low Intensity Resistance Training in Seniors, Old Age and Sarcopenia, sponsored by Kennesaw State University. Recruiting at 1 site in United States. Open to participants aged 65 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-08.
Sponsored by Kennesaw State University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 187 studies in Sarcopenia with a site in United States — 36 open to participants now, 46 under way, 1 of them phase 3. Sarcopenia · United States.
Among the 187 studies in Sarcopenia with a site in United States, this one is the 40th largest by planned enrollment of the 146 interventional ones that give a count, is one of 14 that started in 2026, is one of 101 with no phase, reaches primary completion later than 33 of the 45 other live ones, and was the 183rd registered.
1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.
Browse Sarcopenia studies →36 of the 187 studies in Sarcopenia with a site in United States are open now. Recruiting first, the newest first:
Bettina Mittendorfer · Sites in United States
Ages 18–100 · Healthy volunteers
St. Jude Children's Research Hospital · Sites in United States
Ages 18+ · Healthy volunteers
Ohio State University · Sites in United States
Ages 18+
Health Discovery Labs · Sites in United States
Ages 18–85
Massachusetts General Hospital · Sites in United States
Ages 18+ · Men only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 246 Sarcopenia studies recruiting now, 155 (63%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 62 take healthy volunteers.
This study: 65 Years to 85 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
187 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 18 · Phase 2 24 · Phase 3 3 · Phase 4 5
First in 1995; this study’s year is marked. 14 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 75 is above the median of 60 across 860 interventional studies indexed under Sarcopenia.
Median enrollment 40 across the 146 interventional studies, 70 across the 40 observational. Of the 127 that completed or were terminated, 44 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 187 have an industry lead sponsor. The 10 most frequent:
Kennesaw State University is the lead sponsor of 9 studies on the registry; 4 are open to participants now.
Kennesaw State University has 1 study filed under Sarcopenia — fewer than ten, so there is no comparison to draw.
17 of the studies in Sarcopenia with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05422534Phase 3Vanderbilt University Medical CenterCoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease | 2027-06-20 |
| NCT07421648SynchroHealth LLCBandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4 | 2026-12 |
| NCT06722508University of California, DavisExercise and Nutritional Prehabilitation for Head and Neck Cancer Patients | 2026-12 |
| NCT07029243University of California, San FranciscoPrehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis | 2026-12 |
| NCT06628349Texas A&M UniversityPrandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein | 2026-12 |
Add all 17 to your calendar (.ics) → With an account.
Among the 187 studies in Sarcopenia with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to determine the effect of maximal mental effort combined with low-intensity resistance training on strength and neuromuscular function in older adults. The main questions it aims to answer are:
Participants will be randomly assigned to 1 of 3 groups:
Participants in both training groups will perform 8 weeks of low intensity, whole-body resistance training. Participants in the control group will participate in all testing procedures but not perform any training. Participants from all groups will be instructed to otherwise maintain their normal physical activity levels and dietary habits.
All training sessions will be supervised by research personnel at a Kennesaw State University fitness center. Participants will complete 2 training sessions per week for 8 weeks. Each training session will last about 45-60 minutes and consist of 5 exercises, including both multi-joint (leg press, chest press, back row) and single-joint (knee extension, bicep curl) exercises. Participants will perform 2 sets of 15 repetitions for each exercise for the first 2 weeks, then volume will be increased by progressing to 3 sets for the remaining 6 weeks. There will be a 60-second rest interval between sets and a similar tempo will be used between groups.
Both training groups will perform the same training protocol, but participants in the maximal mental effort group will mentally urge their muscles to contract maximally during each repetition. That is, despite using a low intensity, participants will imagine the feeling of maximal muscle contraction of the primary muscles during each repetition.
Several measures of strength, neuromuscular function, physical function, and body composition will be measured before and after the training or control period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group will perform low intensity, whole-body resistance training.
Behavioral: Low Intensity Resistance Training
This group will perform low intensity, whole-body resistance training with maximal mental effort during muscle contraction.
Behavioral: Low Intensity Resistance Training with Maximal Mental Effort
This group will not perform any training and maintain their regular level of physical activity.
This training intervention will be 8 weeks of low intensity resistance training, including whole-body and isolated muscle exercises, where participants will perform maximal mental effort by imagining maximal muscle contraction during each exercise.
This training intervention will be 8 weeks of low intensity resistance training, including whole-body and isolated muscle exercises.
Change in isokinetic strength of the knee extensors at 60 degrees per second
Dynamic strength of the knee extensors contracting at a constant velocity
Time frame: Baseline, Week 8
Change in isokinetic knee extensor muscle activation as measured by electromyography amplitude
Electromyography root mean square during isokinetic contraction divided by root mean square during isometric contraction
Time frame: Baseline, Week 8
Change in isometric knee extensor strength as measured by newton-meters of torque
Isometric strength of a muscle
Time frame: Baseline, Week 8
Change in knee extensor muscle activation as measured by electromyography amplitude
A measure of the capacity at which the muscle is activated by the nervous system
Time frame: Baseline, Week 8
Change in motor unit firing rate as measured relative to the motor unit recruitment threshold
A measure of how nervous system input produces force output during an isometric contraction
Time frame: Baseline, Week 8
Change in motor unit action potential size as measured relative to the motor unit recruitment threshold
A measure of how nervous system input produces force output during an isometric contraction
Time frame: Baseline, Week 8
Change in handgrip strength as measured in kilograms of force
Upper-body strength as measured by a handgrip dynamometer
Time frame: Baseline, Week 8
Change in walking speed as measured by time taken to walk 4 meters
Measure of lower-body physical function
Time frame: Baseline, Week 8
Change in chair rise performance as measured by number of chair rises performed in 30 seconds
Measure of lower-body physical function
Time frame: Baseline, Week 8
Change in bicep curl strength as measured by load lifted in pounds
Maximum dumbbell load lifted successfully throughout the range of motion of a bicep curl
Time frame: Baseline, Week 8
Change in dynamic strength of the lower body muscles during the leg press as measured by load lifted in pounds for 5 repetitions
Measure of dynamic strength during the leg press exercise
Time frame: Baseline, Week 5, Week 8
Change in muscle composition as measured by ultrasound-derived grey-scale analysis
Echo-intensity value derived from grey-scale analysis is indicative of amount of non-contractile tissue in muscle
Time frame: Baseline, Week 8
Change in skeletal muscle size as measured by ultrasound-derived cross-sectional area
Size of a muscle
Time frame: Baseline, Week 8
Change in fat mass as measured by kilograms
Amount of fat tissue a person possesses estimated by bioelectrical impedance analysis
Time frame: Baseline, Week 8
Change in fat-free mass as measured by kilograms
Amount of non-fat tissue a person possesses estimated by bioelectrical impedance analysis
Time frame: Baseline, Week 8
Change in body fat percentage as measured by fat tissue relative to fat-free tissue
Relative amount of body fat a person possesses estimated by bioelectrical impedance analysis
Time frame: Baseline, Week 8
Change in cognitive function as measured by the Montreal Cognitive Assessment
Assessment of cognitive function where 0 is the lowest score and 30 is the highest score and a higher score represents higher cognitive function.
Time frame: Baseline, Week 8
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2026 (actual). Primary completion is estimated for Dec 2027, 18 months after the start.
Of 497 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's planned 18 months is close to that.
Counting every sponsor, half of 509 studies reached it within 18 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kennesaw State University